This resolution formally designates May 2025 as "ALS Awareness Month" to increase public understanding and support for individuals affected by amyotrophic lateral sclerosis. ALS is a progressive neurodegenerative disease with a short life expectancy, affecting nerve cells in the brain and spinal cord, and currently has no cure. The resolution highlights the significant impact of ALS, noting that tens of thousands of individuals are affected in the United States, with military veterans being more susceptible. The Senate affirms its dedication to ensuring that individuals with ALS receive access to effective treatments and high-quality services as early as possible after diagnosis. This commitment also extends to identifying risk factors and causes to prevent new cases, empowering patients to maintain independence, and reducing the physical and emotional burdens associated with the disease. Furthermore, the resolution commends the tireless efforts of family members, friends, organizations, volunteers, researchers, and caregivers who are working to improve the quality and length of life for ALS patients and develop new treatments and cures.